Literature DB >> 2129297

Progress towards the isolation and characterization of the genes causing neurofibromatosis.

A G Menon1, J F Gusella, B R Seizinger.   

Abstract

The locus for the gene causing neurofibromatosis type 1 (NF1) was bracketed to a region on the long arm of chromosome 17 by means of genetic linkage analysis. When the limits of resolution for genetic mapping were reached physical mapping methods were used to map the NF1 gene precisely, with reference to translocation breakpoints in NF1 affected individuals who harboured constitutional chromosomal translocations on chromosome 17. The region of DNA located between two translocation breakpoints has been cloned and a DNA sequence encoding a 11-13 kb mRNA identified. That this sequence shows deletions and point mutations in NF1 affected individuals and not in normal controls provides strong evidence that it is indeed the NF1 gene. The genetic defect in NF2 has been mapped to chromosome 22 by studies of chromosomal loss in tumours associated with this disease. Subsequent linkage analysis of NF2 pedigrees has confirmed this location. DNA markers that bracket the NF2 locus to a region of 5-10 Mb have been identified.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2129297

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  5 in total

1.  Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.

Authors:  Okay Saydam; Ozlem Senol; Tieneke B M Schaaij-Visser; Thang V Pham; Sander R Piersma; Anat O Stemmer-Rachamimov; Thomas Wurdinger; Saskia M Peerdeman; Connie R Jimenez
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 2.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

3.  MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.

Authors:  Theo L Winther; Sverre H Torp
Journal:  J Neurooncol       Date:  2016-11-21       Impact factor: 4.130

4.  The anti-apoptotic protein survivin can improve the prognostication of meningioma patients.

Authors:  Theo L Winther; Sverre H Torp
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 5.  Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review.

Authors:  Catherine Copley-Merriman; Xiaoqin Yang; Melissa Juniper; Suvina Amin; Hyun Kyoo Yoo; Shuvayu S Sen
Journal:  Adolesc Health Med Ther       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.